BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 122 filers reported holding BRIDGEBIO PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $1,405,000 | -64.8% | 84,250 | +2.3% | 0.83% | -66.0% |
Q3 2021 | $3,990,000 | -15.4% | 82,350 | +6.5% | 2.45% | -22.3% |
Q2 2021 | $4,715,000 | -0.5% | 77,350 | +0.6% | 3.16% | +4.8% |
Q1 2021 | $4,737,000 | -13.4% | 76,900 | 0.0% | 3.01% | -12.8% |
Q4 2020 | $5,468,000 | +98.5% | 76,900 | +4.7% | 3.45% | +61.8% |
Q3 2020 | $2,754,000 | +13.5% | 73,425 | -1.3% | 2.14% | +2.4% |
Q2 2020 | $2,427,000 | +142.5% | 74,425 | +115.7% | 2.08% | +111.8% |
Q1 2020 | $1,001,000 | -17.2% | 34,500 | 0.0% | 0.98% | -0.2% |
Q4 2019 | $1,209,000 | +139.9% | 34,500 | +46.8% | 0.99% | +93.7% |
Q3 2019 | $504,000 | – | 23,500 | – | 0.51% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 3,835,722 | $103,449,000 | 44.18% |
Kohlberg Kravis Roberts & Co. L.P. | 36,900,661 | $995,211,000 | 12.26% |
SC US (TTGP), LTD. | 2,544,738 | $68,632,000 | 4.69% |
Cormorant Asset Management, LP | 2,780,885 | $75,000,000 | 4.31% |
Perceptive Advisors | 6,706,268 | $180,868,000 | 4.15% |
VIKING GLOBAL INVESTORS LP | 26,620,991 | $717,968,000 | 3.22% |
Hillhouse Capital Management | 2,035,790 | $54,905,000 | 1.75% |
Alpine Group USVI, LLC | 20,000 | $539,000 | 1.70% |
HHLR ADVISORS, LTD. | 2,352,900 | $63,458,000 | 1.42% |
SCGE MANAGEMENT, L.P. | 588,235 | $15,865,000 | 0.79% |